{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:08:14Z","timestamp":1785308894100,"version":"3.55.0"},"reference-count":20,"publisher":"Baskent University","issue":"Supp 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.6002\/ect.mesot2025.o53","type":"journal-issue","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:32:51Z","timestamp":1785234771000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Watson CJ, Dark JH. Organ transplantation: historical perspective and current practice. Br J Anaesth. 2012;108 Suppl 1:i29-42. doi:10.1093\/bja\/aer384","DOI":"10.1093\/bja\/aer384"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Wulandari W, Alfaqeeh M, Zakiyah N, Shafie AA, Suwantika AA. Cost-utility analyses of hemodialysis, peritoneal dialysis, and kidney transplantation in patients with end-stage kidney disease: a systematic review. Clinicoecon Outcomes Res. 2025;17:883-895. doi:10.2147\/CEOR.S559471","DOI":"10.2147\/CEOR.S559471"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Khadjibaev F, Sultanov P, Ergashev D, et al. State of transplantation in the Republic of Uzbekistan: existing problems of donation. Exp Clin Transplant. 2024;22(Suppl 1):66-69. doi:10.6002\/ect.MESOT2023.O4","DOI":"10.6002\/ect.MESOT2023.O4"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Hanson S, Menendez Lorenzo J, Chukwu CA, Rao A, Middleton R, Kalra PA. Incidence, risk factors and survival outcomes of post-transplant tertiary hyperparathyroidism in kidney recipients. World J Transplant. 2026;16(1):103656. doi:10.5500\/wjt.v16.i1.103656","DOI":"10.5500\/wjt.v16.i1.103656"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11(3):450-462. doi:10.1111\/j.1600-6143.2010.03283.x","DOI":"10.1111\/j.1600-6143.2010.03283.x"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Opelz G, Dohler B, Collaborative Transplant S. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005;5(11):2725-2731. doi:10.1111\/j.1600-6143.2005.01093.x","DOI":"10.1111\/j.1600-6143.2005.01093.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Khadjibaev FA, Sharipova VK, Sultanov PK. Analysis of complications after living-related kidney transplantation: a single-center experience. Russian J Transplant. 2021;13(1):63-73. doi:10.23873\/2074-0506-2021-13-1-63-73","DOI":"10.23873\/2074-0506-2021-13-1-63-73"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Khadjibaev A, Khadjibaev F, Rakhimova R, et al. Three-year experience of kidney transplantation at a single center in Uzbekistan. Exp Clin Transplant. 2022;20(Suppl 1):24-30. doi:10.6002\/ect.MESOT2021.O10","DOI":"10.6002\/ect.MESOT2021.O10"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Khadjibaev F, Sultanov P, Ergashev D, et al. Frequency of complications after kidney transplant in the early postoperative period. Exp Clin Transplant. 2024;22(Suppl 1):195-199. doi:10.6002\/ect.MESOT2023.P25","DOI":"10.6002\/ect.MESOT2023.P25"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007;357(25):2562-2575. doi:10.1056\/NEJMoa067411","DOI":"10.1056\/NEJMoa067411"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4(2):481-508. doi:10.2215\/CJN.04800908","DOI":"10.2215\/CJN.04800908"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. de Winter BC, Mathot RA, van Hest RM, van Gelder T. Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome? Expert Opin Drug Metab Toxicol. 2007;3(2):251-261. doi:10.1517\/17425255.3.2.251","DOI":"10.1517\/17425255.3.2.251"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Shaw LM, Korecka M, Venkataramanan R, Goldberg L, Bloom R, Brayman KL. Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant. 2003;3(5):534-542. doi:10.1034\/j.1600-6143.2003.00079.x","DOI":"10.1034\/j.1600-6143.2003.00079.x"},{"key":"ref13","unstructured":"14. Gautier SV, ed. Transplantology: Results and Prospects. Triada Publishing House; 2014, volume V. ISBN 978-5-94789-649-7"},{"key":"ref14","unstructured":"15. Gautier S.V. A current status of transplantation in the Russian Federation. Russian J Transplant. 2012;(4):14-19. Doi:10.23873\/2074-0506-2012-0-4-14-19"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Allazova SS, Novikova MS, Kotenko ON, Shilov EM. [Immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation]. Ter Arkh. 2020;92(12):137-141. doi:10.26442\/00403660.2020.12.200454","DOI":"10.26442\/00403660.2020.12.200454"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Hecking M, Sharif A, Eller K, Jenssen T. Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics. Transpl Int. 2021;34(1):27-48. doi:10.1111\/tri.13783","DOI":"10.1111\/tri.13783"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Loupy A, Lefaucheur C. Antibody-mediated rejection of solid-organ allografts. N Engl J Med. 2018;379(12):1150-1160. doi:10.1056\/NEJMra1802677","DOI":"10.1056\/NEJMra1802677"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Gaston RS, Fieberg A, Hunsicker L, et al. Late graft failure after kidney transplantation as the consequence of late versus early events. Am J Transplant. 2018;18(5):1158-1167. doi:10.1111\/ajt.14590","DOI":"10.1111\/ajt.14590"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Gulov MK, Pirov BS. Causes of kidney transplant dysfunction and methods of its correction. Avicenna Bull. 2017;19(4):532-536. doi:10.25005\/2074-0581-2017-19-4-532-536","DOI":"10.25005\/2074-0581-2017-19-4-532-536"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:48:41Z","timestamp":1785307721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2026\/24\/6\/2\/137\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"journal-issue":{"issue":"Supp 2","published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2025.o53","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}